Clinical Trial Update: Time Course of Response to Methylphenidate HCl ER Capsules in Children 6 to 12 Years With ADHD in Classroom Setting [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children aged 6 to 12 with ADHD in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate HCl ER Capsule (methylphenidate hydrochloride extended-release)

Snippet

Sponsor: Rhodes Pharmaceuticals, L.P. | Conditions: Attention Deficit Hyperactivity Disorder, ADHD | Phase 3 | Status: COMPLETED | Results posted: 2022-12-13